Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
ABBOTT BIOTHERAPEUTICS CORP (FACT) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/27/2010 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
05/03/2010 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
04/23/2010 8-K Quarterly results
04/22/2010 25-NSE Form 25-NSE -
04/21/2010 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
04/21/2010 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership
04/21/2010 SC 13G FACET BIOTECH CORP reports a 0% stake in Facet Biotech Corp
04/20/2010 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
04/19/2010 10-K/A Annual Report for the period ended December 31, 2009 [amend]
04/15/2010 10-Q/A Quarterly Report for the period ended September 30, 2009 [amend]
04/13/2010 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements
04/12/2010 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
04/08/2010 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
04/05/2010 8-K Form 8-K - Current report
04/05/2010 MW Facet Biotech Announces Two Presentations at American Academy of Neurology Annual Meeting
03/23/2010 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements
03/23/2010 SC TO-T Form SC TO-T - Tender offer statement by Third Party
03/19/2010 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership
03/17/2010 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
03/15/2010 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
03/12/2010 BW Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Facet Biotech Corporation by Abbott Laboratories
03/11/2010 8-A12B/A Form 8-A12B - Registration of securities [Section 12(b)] [amend]
03/10/2010 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta...
Docs: "Agreement and Plan of Merger, among Abbott Laboratories, Amber Acquisition Inc. and Facet Biotech Corporation",
"Third Amendment to Rights Agreement, by and between Facet Biotech Corporation and Mellon Investor Services, LLC, as rights agent",
"Scott Stoffel 936-9502 Abbott Investors: Larry Peepo 847-935-6722 Facet Media: Cindy Leggett-Flynn 333-3810 Facet Investors: Jean Suzuki 454-2648 Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech"
03/10/2010 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
03/10/2010 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
03/10/2010 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
03/10/2010 BW Kendall Law Group Investigates Facet Biotech Corporation Merger for Shareholders
03/10/2010 BW Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Facet Biotech Corporation
03/09/2010 BW Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Facet Biotech Corporation - FACT
02/26/2010 8-K Quarterly results, Conference call transcript
Docs: "FACET BIOTECH REPORTS FOURTH QUARTER AND FULL YEAR 2009 FINANCIAL RESULTS",
"Transcript of Webcast conference call held on February 23, 2010 regarding the financial results of Facet Biotech Corporation for the fourth quarter and full year ended December 31, 2009"
02/23/2010 10-K Annual Report for the period ended December 31, 2009
02/16/2010 SC 13G/A NB Public Equity K/S reports a 9% stake in Facet Biotech Corporation
02/09/2010 8-K Form 8-K - Current report
02/03/2010 8-K Termination of a Material Definitive Agreement
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy